Image:  May 14, 2009 China Evening: Advancing Patient Care Through International Clinical Study Collaboration Co-organized by Medtronic, Biosense Webster, and CnAHA Time: 18:30 - 20:30, May 14, 2009 Address: Venue: Salon E, Fourth Floor, Marriott Copley Place Boston 6:30 pm - 7:10 pm Welcome speech by Heart Rhythm Society Representatives (10 min) Richard Page, MD, FHRS, President, Heart Rhythm Society Thomas F. Deering, MD, FHRS, CCDS, Chair, HRS Membership Committee James Youngblood, CEO of HRS Speech by Chinese Society of Cardiac Pacing and Electrophysiology (CSPE) and Chinese Heart Rhythm Society (CHRS) (10 min) Zhang Shu, MD, PhD, Director, Cardiac Arrhythmia Center, Cardiovascular Institute and Fuwai Hospital; Clinical Professor, Chinese Academy of Medical Science & Beijing Union Medical College, Beijing, China Ma Chang-Sheng, MD, PhD, Director, Cardiac Electrophysiology, Beijing Anzhen Hospital, Clinical Professor, Capital University of Medical Sciences Clinical Study collaboration briefing by physicians (20 min) China PANORAMA & COMPARE Study briefing by Dr. Chen Ke-Ping BE CAREFUL Study briefing by Dr. Li Jian-Ming / Dr. Hua Weil EP Study by Dr. Ma Chang-Sheng / Dr. Liu Xing-Peng / Dr. Du Xin 7:10 pm - 8:00 pm Dinner Buffet 8: 00 pm - 8:30 pm        1. The introduction of Chinese American Heart Association (5 min): Jian-Ming Li, MD, PhD, Vice President, CnAHADirector of Cardiac Pacing and Electrophysiology, Director of EP Fellowship Program, VA Medical Center, University of Minnesota 2. The CnAHA sponsored Outstanding Award ― An initiative (5 min) Jie Cheng, MD, PhD, Chair of Academic Affairs, CnAHA Director of Electrophysiology Research; Clinical Associate Professor at Baylor College of Medicine, Texas Heart Institute 3. The collaborative ARVD studies in China and in the US (5 min) Li Zhang, MD, Chair of Electrophysiology, CnAHA Director, Cardiovascular Outcomes Research, Main Line Health Heart Center Clinical Associate Professor, Lankenau Institute of Medical Research 4. CnAHA Invited Lecture (10 min): Arrhythmogenic Right Ventricular Dysplasia and Myocarditis ―Congestive Heart Failure and Sudden Death! Keynote speaker―Guy Fontaine, MD, PhD, is a world renowned pioneer investigator of ARVD. In 70's Dr. Fontaine first recognized a distinct type of cardiomyopathy in mostly young and healthy individuals suffered with drug refractory ventricular tachycardia (VT) and named it arrhythmogenic right ventricular dysplasia (ARVD). He first identified the critical zone of slow conduction in VT (concealed entrainment) in ARVD, the underlying cause of late potentials and Epsilon waves. He found that patients with ARVD (as well as other cardiomyopathies) are prone to inflammation (myocarditis), which has important prognostic implications. He first reported apoptosis in those older patients with ARVD progress to congestive cardiac failure. A new treatment can be dynamic cardiomyoplasty. Dr. Fontaine has more than 160 publications (including many book chapters) regarding the diagnosis and treatment of ARVD. 5. Recommendations for future Chinese ARVD studies (5 min) Guest speaker―Frank Marcus, MD, is a Professor of Medicine at the University of Arizona, College of Medicine, in Tucson, Arizona. His area of expertise is Clinical Cardiology, Cardiovascular Pharmacology and Clinical Electrophysiology. Dr. Marcus is a dedicated researcher in Arrhythmogenic Right Ventricular Dysplasia (ARVD) for over 27 years. He is the Director of North American ARVD Registry with over 90 ARVD study publications in peer reviewed medical journal.